Cardiofaciocutaneous Syndrome

Disease Overview

Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder characterized by distinctive physical abnormalities and developmental challenges. It is part of the RASopathies, a group of conditions caused by mutations affecting the RAS-MAPK cellular signaling pathway, which impacts cell growth, division, and differentiation.

Disease Category

Rare genetic disorder
Congenital condition
Neurodevelopmental syndrome
RASopathy

Synonyms

CFC Syndrome
Cardiofaciocutaneous Syndrome
CFC Syndrome type 1
CFC Syndrome type 2

Signs & Symptoms

Key manifestations include:

Cardiac Abnormalities: - Congenital heart defects - Atrial septal defects (ASD) - Ventricular septal defects (VSD) - Pulmonary stenosis - Hypertrophic cardiomyopathy

Facial Features: - High forehead - Macrocephaly - Bitemporal narrowing - Ptosis (drooping eyelids) - Low-set ears - Distinctive facial characteristics

Cutaneous Manifestations: - Dry, thick, scaly skin - Ichthyosis - Keratosis pilaris - Sparse hair - Absent or minimal eyebrows

Neurological/Developmental: - Developmental delays - Intellectual disability - Hypotonia - Feeding difficulties - Potential seizures - Growth delays

Causes

Genetic Mutations: - BRAF gene (most common) - MAP2K1 gene - MAP2K2 gene - KRAS gene

Pathogenesis involves disrupted RAS-MAPK signaling pathway, leading to abnormal cellular development and function.

Affected Populations

Prevalence: Extremely rare
Incidence: Approximately 1 in 810,000 live births
No significant gender predilection
Occurs across all ethnic backgrounds

Disorders with Similar Symptoms

Noonan Syndrome
Costello Syndrome
LEOPARD Syndrome
Neurofibromatosis type 1
Other RASopathies

Diagnosis

Diagnostic Approach: - Comprehensive clinical evaluation - Detailed family history - Physical examination - Genetic testing for specific mutations - Cardiac imaging (echocardiogram) - Neurological assessment - Dermatological examination

Standard Therapies

Multidisciplinary Management: - Cardiac monitoring and intervention - Early developmental interventions - Physical therapy - Occupational therapy - Speech therapy - Nutritional support - Specialized skincare - Symptomatic treatment of specific complications

Clinical Trials and Studies

Research Platforms: - ClinicalTrials.gov - National Institutes of Health (NIH) - Rare Diseases Clinical Research Network - International RASopathies research collaborations

References

Genetic and Rare Diseases Information Center
National Organization for Rare Disorders
Published genetic research journals

Programs & Resources

CFC International
The RASopathies Network
Genetic Counseling Services
National Organization for Rare Disorders (NORD)

Complete Report

Cardiofaciocutaneous syndrome represents a complex genetic condition requiring comprehensive, personalized medical management. Ongoing research continues to improve understanding of its molecular mechanisms and potential therapeutic interventions.